Published: 03 April, 2020 | Volume 3 - Issue 1 | Pages: 001-020
Figure 1:
Upper part: The discovery by Constantinescu & Vainchenker of the JAK2V617F somatic mutation as the cause of trilinear myeloproloferative neoplasms and the sequential occurrence of heterozygous JAK2V617F mutation in essential thrombocythemia (ET) and homozygous JAK2V617F mutation in trilinear polycythemia vera (PV) which does explain the occurrence of three sequential phenotypes of ET, PV and myelofibrosis (MF) during life long follow-up in the studies of Dameshek and Michiels. Lower part: Concept of Michiels & De Raeve on the dynamics of the JAK2V617F disease processes in trilinear MPN ranged from normocellular ET and prodromal PV mimicking ET with normal erythrocyte count below 5.8x1012/L to defintive increase in peripheral blood erythrocytes above 5.8x1012/L) in PV followed by masked PV, advanced PV complicated by fibrosis and splenomegaly, spentphase PV and blast transformation of post - PV myelofibrosis. Designedby Michiels 2020.
Read Full Article HTML DOI: 10.29328/journal.ijbmr.1001011 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."